ARTICLE | Company News
Novartis withdraws EU application for aliskiren/valsartan
September 18, 2010 12:17 AM UTC
The European Medicines Agency (EMA) said Novartis AG (NYSE:NVS; SIX:NOVN) withdrew an MAA for Rasival aliskiren/valsartan to treat hypertension. According to the agency, the pharma said it would not b...